Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Pathology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Clin Endocrinol (Oxf). 2018 Jan;88(1):96-104. doi: 10.1111/cen.13397. Epub 2017 Jul 18.
Thyroid core needle biopsy (CNB) is increasingly being used as a tool for evaluating thyroid nodules; thus, standardization of its diagnostic terminology is called for. We aimed to analyse the pathologic reporting system of thyroid CNB based on the recently proposed protocol by the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group and evaluate its usefulness.
DESIGN/METHODS: A total of 1998 consecutive cases of thyroid CNBs were reviewed and divided into six categories according to the protocol. Malignancy rate in each category and the diagnostic performance of thyroid CNB were calculated using 705 resected cases.
Thyroid CNB yielded 132 nondiagnostic (6.6%), 791 benign (39.6%), 328 indeterminate (16.4%), 227 follicular neoplasm (11.4%), 69 suspicious for malignancy (3.5%) and 451 malignant lesions (22.6%). In resected specimens, all of the cases designated as suspicious for malignancy and malignant categories in CNB were proven to be true malignant lesions. Lesions diagnosed with follicular neoplasm in CNB were identified as malignant lesions in 57.0%. Malignancy rate was significantly higher in indeterminate lesions with nuclear atypia compared to those with architectural atypia (80.0% vs 28.2%). When CNB diagnoses of indeterminate lesions or higher categories were considered positive, the sensitivity and positive predictive value for final malignant diagnoses were 99.2% and 81.3%, respectively.
CNB is an accurate method of evaluating thyroid nodules and can serve as an alternative to fine needle aspiration when it is used and reported according to standardized diagnostic categories.
甲状腺细针穿刺活检(CNB)越来越多地被用作评估甲状腺结节的工具;因此,需要对其诊断术语进行标准化。我们旨在分析基于韩国内分泌病理甲状腺细针穿刺活检研究组最近提出的方案的甲状腺 CNB 病理报告系统,并评估其有用性。
设计/方法:共回顾了 1998 例连续的甲状腺 CNB 病例,并根据该方案分为六类。使用 705 例切除病例计算了每种类别中的恶性肿瘤发生率和甲状腺 CNB 的诊断性能。
甲状腺 CNB 获得 132 例非诊断性(6.6%)、791 例良性(39.6%)、328 例不确定(16.4%)、227 例滤泡性肿瘤(11.4%)、69 例疑似恶性(3.5%)和 451 例恶性病变(22.6%)。在切除标本中,所有在 CNB 中被诊断为疑似恶性和恶性类别的病例均被证实为真正的恶性病变。在 CNB 中诊断为滤泡性肿瘤的病变中有 57.0%被确定为恶性病变。核异型性的不确定病变的恶性肿瘤发生率明显高于结构异型性的不确定病变(80.0%比 28.2%)。当将 CNB 诊断为不确定病变或更高类别视为阳性时,最终恶性诊断的敏感性和阳性预测值分别为 99.2%和 81.3%。
CNB 是评估甲状腺结节的一种准确方法,当按照标准化的诊断类别使用和报告时,它可以替代细针抽吸。